ERBB2 and bone metastasis: In fact, beside bone metastasis, which is observed with all subtypes, brain metastasis seems to be more frequent in HR−/HER2+ patients and liver metastasis is more frequent in HER2+ than in HER2− subtypes, while secondary lung involvement is more common in triple negative (TN) tumors [13].